Breath pentane as a marker for lipid peroxidation and adverse outcome in preterm infants

Archives of Disease in Childhood: Fetal and Neonatal Edition

Volumn 79, Issue 1, 1998, Pages

  Nycyk, J A ^a   Drury, J A ^a   Cooke, R W I ^a  

^a LIVERPOOL WOMEN S HOSPITAL   (United Kingdom)

Author keywords

Breath pentane; Lipid peroxidation; Oxygen derived free radicals

Indexed keywords

ANTIOXIDANT; FREE RADICAL; LUNG SURFACTANT; PENTANE;

ARTICLE; ARTIFICIAL VENTILATION; BREATH ANALYSIS; CHRONIC LUNG DISEASE; DISEASE SEVERITY; FEMALE; HUMAN; INFANT; LIPID PEROXIDATION; MAJOR CLINICAL STUDY; MALE; NEWBORN INTENSIVE CARE; PATIENT MONITORING; PREMATURITY; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 0031854797     PISSN: 13592998     EISSN: 14682052     Source Type: Journal    
DOI: 10.1136/fn.79.1.F67     Document Type: Article

References (13)

1. Saugstadt OD. Hypoxanthine as an indicator of hypoxia: its role in health and disease through free-radical production. Pediair Res 1988;23:143-50.
2. Inder TE, Graham P, Sanderson K, Taylor BJ. Lipid peroxidation as a measure of oxygen free radical damage in the very low birthweight infant. Arch Dis Child 1994;70:F107-11.
3. Schlenzig JS, Bervoets K, von Loewenich V, Bohles H. Urinary malondialdehyde in preterm neonates; is there a relationship to disease entities of neonatal intensive care? Acta Paedatr 1993;82:202-5.
4. Pitkanen OM, Hallman M, Andersson SM. Correlation of free oxygen radical-induced lipid peroxidation with outcome in very low birthweight infants. J Pediatr 1990;116:760-4.
5. Pitkanen OM, Hallman M, Andersson SM. Generation of free radicals in lipid emulsion used in parenteral nutrition. Pediatr Res 1991;29:56-9.
6. Varsila E, Pitkanen O, Hallman M, Andersson S. Immaturity-dependent free radical activity in premature infants. Pediatr Res 1994;36:55-9.
7. Drury JA, Nycyk JA, Cooke RWI. Pentane measurement in ventilated infants using a commercially available system. Free Radical Biol Med 1997;22:895-900.
8. Papille LA, Birskin J, Birskin R, Koffler H. Incidence and evolution of subependymal and intraventricular haemorrhage: a study of infants with birthweights less than 1500 gm. J Pediatr 1978;92:529-34.
9. Committee fo the classification of retinopathy of prematurity. International classification of ROP. Pediatrics 1984;74:127-33.
10. Arnon S, Grigg J, Silverman M. Pulmonary inflammatory cells in ventilated preterm infants: effect of surfactant treatment. Arch Dis Child 1993;69:44-8.
11. Chiswick ML, Johnson M, Woodhall C. Protective effect of vitamin E (dl-alpha-tocopherol) against intraventncular haemorrhage in premature babies. BMJ 1983;287:81-4.
12. Shenai JP, Kennedy KA, Chytil F, Stahlman MT. Clinical trial of vitamin A supplementation in infants susceptible to bronchopulmonary dysplasia. J Pediair 1987;111:269-77.
13. Rosenfeld W, Evans H, Concepcion L, Jhaveri R, Schaeffer H, Friedman A. Prevention of bronchopulmonary dysplasia by administration of bovine Superoxide dismutase in preterm infants with respiratory distress syndrome. J Pediatr 1984;105:781-5.